Brussels, Belgium (PRWEB UK) 25 June 2014
The partners of the ENTENTE-project together with the European Commission and EuropaBio would like to announce the EuropaBio’s 5th Most Innovative European Biotech SME Award and the ENTENTE Life Sciences Investment Forum, taking place during the 2014 European Biotech Week (http://www.e-unlimited.com/mci.aspx?mci_id=13911&mc_sent_id=547103) in Brussels . These events will be especially dedicated to strengthening the life sciences innovation potential in Europe through promoting and empowering innovative SMEs seeking financial facilitations and international exposure.
8 October: EuropaBio’s 5th Most Innovative European Biotech SME Award
This year, EuropaBio will be hosting its 5th annual Most Innovative Biotech SME Award. The event will include presentations from the European Commission and the European Investment Bank on the most recent European financial facilitations for innovative SMEs. This year’s award will be presented by European Commission Director General for Enterprise and Industry, Daniel Calleja-Crespo.
Find out more information here: http://www.europabio.org/europabio-most-innovative-european-biotech-sme-award-2014-now-open-applications .
Companies application deadline: July 1st
For further information on the EuropaBio’s 5th Most Innovative European Biotech SME Award please contact Rosalind Travers from EuropaBio via mail at R.Travers(at)europabio(dot)org or via phone at +32 (0) 2 739 1173.
9 October: ENTENTE- Life Sciences Investment Forum
The event will unite 28 European early stage innovative companies active in the Life Sciences sector and seeking investment opportunities and international exposure. The selected companies will pitch their innovation, developments and needs in front of an international jury consisting of about 40 business angels, venture capitalists, corporate investors and other industry experts. Representatives of DSM Venturing, GlaxoSmithKline, Omnes Capital, Sofimac Partners, Sunstone Capital, Wellington Partners have – among others – already confirmed their participation as jury members.
Throughout the day participants will have the opportunity to assist to inspiring panel discussions from key players of the industry and to innovative companies presentations, and have plenty of networking opportunities including targeted one2one meetings.
Find out more information here: http://www.e-unlimited.com/Entente.
Companies application deadline : August 29th
For further information on the ENTENTE Life Sciences Investment Forum please contact Annalisa Gardella from Europe Unlimited via mail at annalisa(at)e-unlimited(dot)com or via phone at +32 (0) 2 643 36 91.
EuropaBio is the European Association of BioIndustries. Its members are involved in research, development, testing, manufacturing and commercialisation of biotech products and processes in human and animal healthcare, diagnostics, bioinformatics, chemicals, crop protection, agriculture, food and environmental products and services. EuropaBio also counts a number of National Biotech Associations in its membership who in turn represents more than 1800 SMEs.
ENTENTE (FP7 project) is the first European network to boost knowledge transfer activity in health research among academic and public organisations and industrial counterpart. The project promotes transnational collaboration among all stakeholders through networking activities, sharing experience and best practices and implementing an exchange programme for professionals of Technology Transfer in Health.